Clinical Trials
10
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
A Registry： Siltartoxatug Injection for Tetanus Prophylaxis Following Injury
- Conditions
- Tetanus
- First Posted Date
- 2025-08-06
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Target Recruit Count
- 10000
- Registration Number
- NCT07107932
- Locations
- 🇨🇳
The Second Affiliated Hospital of Shantou University, Shantou, Guangdong, China
🇨🇳Xiangyun County People's Hospital, Xiangyun, Yunnan, China
🇨🇳Shaoxing Central Hospital, Shaoxing, Zhejiang, China
A Sudy to Evaluate the Efficacy and Safety of TNM001 in High-risk Infants
- Conditions
- Respiratory Syncytial Virus Infections
- Interventions
- Biological: placebo
- First Posted Date
- 2024-11-29
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Target Recruit Count
- 201
- Registration Number
- NCT06710925
- Locations
- 🇨🇳
West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China
🇨🇳Children's Hospital of Chongqing Medical University, Chongqing, Sichuan, China
A Randomized, Open-Label, Parallel-Design Pharmacokinetic and Pharmacodynamic Interaction Study of TNM002 and Adsorbed Tetanus Vaccine
- Conditions
- Tetanus
- Interventions
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2024-09-23
- Lead Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT06607380
- Locations
- 🇨🇳
PKUCare Luzhong Hospital, Zibo, Shandong, China
A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants
- Conditions
- Respiratory Syncytial Virus Infections
- First Posted Date
- 2023-10-16
- Last Posted Date
- 2023-10-16
- Lead Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Target Recruit Count
- 2250
- Registration Number
- NCT06083623
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
🇨🇳Children's Hospital Capital Institute Pediatrics, Beijing, Beijing, China
🇨🇳Jiangjin Central Hospital, Chongqing, Chongqing, China
A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjectsy
- First Posted Date
- 2023-10-05
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT06068608
- Locations
- 🇺🇸
ICON, plc, Salt Lake City, Utah, United States
- Prev
- 1
- 2
- Next